Skip to content

Envoy Medical COCH Other Equity

Other Equity at other companies

Envoy Medical logo
Envoy MedicalCOCH
$10M0.0%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$8M
RFL
Rafael Holdings, Inc.RFL
$100M0.0%
EFC
Ellington Financial Inc.EFC
$2.07B+24.3%
Signet Jewelers logo
Signet JewelersSIG
$400K0.0%
Accenture logo
AccentureACN
$2.47B

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:OtherAdditionalCapital.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's other equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's other equity?
Envoy Medical (COCH) reported other equity of $10M in Q1 2026.
How has Envoy Medical's other equity changed year-over-year?
Envoy Medical's other equity decreased by 0.0% year-over-year, from $10M to $10M.
What is the long-term trend for Envoy Medical's other equity?
Over 2 years (2023 to 2025), Envoy Medical's other equity has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.
What does other equity mean?
Captures miscellaneous equity components that do not fall into standard categories like retained earnings or common stock. It provides a comprehensive view of the total residual interest in the company's assets after deducting liabilities.